Literature DB >> 26600215

Epidemiology of Hepatitis C Virus: A Battle on New Frontiers.

Norah J Shire1, Kenneth E Sherman2.   

Abstract

The hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality in the United States and other parts of the world. The epidemiology of the disease is highly variable between and within countries, and strategies to deal with HCV identification and treatment must be tailored to the geographic location and the political and economic environment of the region. Although great strides have been made in improving HCV transmission risk in blood supply products, new challenges related to changing patterns of disease incidence continue to require fresh evaluation and new approaches to disease prevention.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute HCV; Co-infection; HCV epidemiology; Incidence; Prevalence

Mesh:

Year:  2015        PMID: 26600215     DOI: 10.1016/j.gtc.2015.07.002

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  8 in total

Review 1.  Viral-Associated GN: Hepatitis C and HIV.

Authors:  Warren L Kupin
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

Review 2.  Tumour virus epidemiology.

Authors:  Ruth M Lunn; Gloria D Jahnke; Charles S Rabkin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

Review 3.  Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population.

Authors:  Arun Rajasekaran; Ricardo A Franco; Edgar T Overton; Brendan M McGuire; Graham C Towns; Jayme E Locke; Deirdre L Sawinski; Emmy K Bell
Journal:  Kidney Int Rep       Date:  2021-04-25

Review 4.  Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.

Authors:  Stefano Ballestri; Fabio Nascimbeni; Dante Romagnoli; Enrica Baldelli; Giovanni Targher; Amedeo Lonardo
Journal:  Int J Mol Sci       Date:  2016-03-09       Impact factor: 5.923

Review 5.  State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization.

Authors:  Cecilia Trucchi; Andrea Orsi; Cristiano Alicino; Laura Sticchi; Giancarlo Icardi; Filippo Ansaldi
Journal:  J Immunol Res       Date:  2016-10-24       Impact factor: 4.818

Review 6.  Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence.

Authors:  Roberto Nuño Solinís; Patricia Arratibel Ugarte; Ander Rojo; Yuri Sanchez Gonzalez
Journal:  Infect Dis Ther       Date:  2016-10-25

7.  Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.

Authors:  Andrew J Gilman; An K Le; Changqing Zhao; Joseph Hoang; Lee A Yasukawa; Susan C Weber; John M Vierling; Mindie H Nguyen
Journal:  BMJ Open Gastroenterol       Date:  2018-05-05

8.  Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.

Authors:  Adugna Endale Woldegiorgis; Woldearegay Erku; Girmay Medhin; Nega Berhe; Mengistu Legesse
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.